Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
用户5WPLEMRwnV3I
7个月前
226
10
已完结
1. 系统已在2025-03-13 17:40:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.atherosclerosis.2025.119120
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0021915025000176
其他信息:
出版社: Elsevier BV
作者: Jie Lin; Yuan Ji; Gaopin Wang; Xueping Ma; Zhuhua Yao; Xuebin Han; Jie Chen; Jiyan Chen; Wei Huang; Guangma Xu; Daoquan Peng; Peishi Yan; Ping Qiao; Yongming He; Yida Tang; Minghui Wang; Mengqi Zhang; Jianjun Yu; Yu Hao; Changsheng Ma
